Document Detail

Anticoagulants, antiplatelets, and statins in heart failure.
MedLine Citation:
PMID:  18312905     Owner:  NLM     Status:  MEDLINE    
The existing guidelines for the treatment of patients who have heart failure limit the administration of antiplatelet and anticoagulant agents to patients who have specific comorbidities, including coronary artery disease, atrial fibrillation, history of thromboembolic events, and left ventricular mural thrombus. Retrospective analyses of large clinical trials or smaller nonrandomized studies indicate that the use of statins may be beneficial both in ischemic and idiopathic dilated cardiomyopathy. This article outlines the current knowledge regarding the use of antiplatelet and anticoagulant agents and statins in patients who have heart failure.
Dimitrios Farmakis; Gerasimos Filippatos; Mitja Lainscak; John T Parissis; Stefan D Anker; Dimitrios T Kremastinos
Related Documents :
8996255 - Medical issues and emergencies in the dermatology office.
7681375 - Defibrotide. a review of its pharmacodynamic and pharmacokinetic properties, and therap...
6684535 - Plasminogen activator content in heart tissue and perfusate under various experimental ...
11872915 - Emergent use of anticoagulation for treatment of patients with ischemic stroke.
23880945 - Concealed pheochromocytoma presenting as recurrent acute coronary syndrome with stemi :...
18606865 - Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Cardiology clinics     Volume:  26     ISSN:  0733-8651     ISO Abbreviation:  Cardiol Clin     Publication Date:  2008 Feb 
Date Detail:
Created Date:  2008-03-03     Completed Date:  2008-04-15     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8300331     Medline TA:  Cardiol Clin     Country:  United States    
Other Details:
Languages:  eng     Pagination:  49-58, vi     Citation Subset:  IM    
University of Athens Medical School, Attikon University Hospital, Athens, Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anticoagulants / administration & dosage*
Aspirin / administration & dosage
Drug Administration Schedule
Heart Failure / drug therapy*
Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage*
Platelet Aggregation Inhibitors / administration & dosage*
Warfarin / administration & dosage
Reg. No./Substance:
0/Anticoagulants; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors; 0/Platelet Aggregation Inhibitors; 50-78-2/Aspirin; 81-81-2/Warfarin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Neutral endopeptidase inhibitors and endothelin antagonists.
Next Document:  Traditional and novel approaches to management of heart failure: successes and failures.